EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study

Jonathan Huggins iD, Julia A Messina iD, Jennifer Saullo, Jiayi Xie iD, Amy Zhang, Ishan Paranjpe, Rong Lu, Megan Walsh, Michael Mohnasky iD, Joseph Stromberg, Felicia Cao, Natalie Grover iD und 13 weitere

Open Forum Infectious Diseases · 01.07.2026 · 13 (7)

DOI: 10.1093/ofid/ofag423 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 03.07.2026. Verfasst von Jonathan Huggins und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIAID, Amy Strelzer Manasevit Foundation Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Our understanding of the epidemiology of and risk factors for postchimeric antigen receptor T-cell therapy (CART) infections is largely based on data from single-center studies with small sample sizes.

Methods

This is a multicenter, cohort study of adult patients treated with CD19 CART between 1 January 2018 and 31 August 2021. The epidemiology of infectious complications occurring within the first year after CART is described. A Fine-Gray subdistribution hazard model was built to identify risk factors for infection. Logistic regression was used to explore risk factors for early (≤90 days post-CART) versus late (>90 days post-CART) and bacterial versus viral infection.

Results

One hundred and thirty-one infections occurred in 97 of 311 patients (31.2%) within 1 year of CART. By infection type, the cumulative incidence of infection was 19.0% (viral), 20.9% (bacterial), and 2.3% (fungal). The majority of infections were mild or moderate in severity (86%). Clostridiodes difficile and bloodstream infections due to Gram-negative bacilli were common bacterial infections. Respiratory viral infections were the most common viral complication and fungal infections were rare. No independent predictors of infection were identified.

Conclusions

Infectious complications occur in close to a third of patients post-CART but are generally mild in severity. Though we were not able to identify independent predictors of post-CART infection, a description of their clinical characteristics and epidemiology will help to optimize management of these common complications.

Schlagwörter

Stichwörter der Autor:innen

CD19bacterialchimeric antigen Receptor T-cellfungalimmunocompromised hostlymphomaviral

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Division of Blood & Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, California, USA.
  • Department of Medicine, Quantitative Sciences Unit, Stanford University, Stanford, California, USA.
  • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Medicine, Stanford University Hospital, Stanford, California, USA.
  • Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USA.

ORCID-Profile: Jonathan Huggins, Julia A Messina, Jiayi Xie, Michael Mohnasky, Natalie Grover, Melody Smith, Tessa M Andermann

Förderung

  • NIAID NIH HHS
  • NIAID
  • Amy Strelzer Manasevit Foundation Award

Zitieren

APA

Huggins, J., Messina, J. A., Saullo, J., Xie, J., Zhang, A., Paranjpe, I., Lu, R., Walsh, M., Mohnasky, M., Stromberg, J., Cao, F., Grover, N., Saha, M., Darwin, A., Torres, N., Tam, P., Schrum, D., Eberwein, E., Kennedy, E., …, & Andermann, T. M. (2026). Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study. Open Forum Infectious Diseases, 13(7). https://doi.org/10.1093/ofid/ofag423

Vancouver

Huggins J, Messina JA, Saullo J, Xie J, Zhang A, Paranjpe I, et al. Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study. Open Forum Infectious Diseases. 2026;13(7). doi:10.1093/ofid/ofag423

BibTeX
@article{Huggins2026,
  author = {Huggins, Jonathan and Messina, Julia A and Saullo, Jennifer and Xie, Jiayi and Zhang, Amy and Paranjpe, Ishan and Lu, Rong and Walsh, Megan and Mohnasky, Michael and Stromberg, Joseph and Cao, Felicia and Grover, Natalie and Saha, Manish and Darwin, Alicia and Torres, Nancy and Tam, Patrick and Schrum, Daniel and Eberwein, Erin and Kennedy, Erin and Kelsey, Christopher R and Choi, Taewoong and McKinney, Matthew and Kang, Yubin and Smith, Melody and Andermann, Tessa M},
  title = {Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort Study},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {7},
  doi = {10.1093/ofid/ofag423}
}
Kostenlos starten →